Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance "shake-up". Bowie K. BMJ 2025;390:r1777.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Bowie K. Type 2 diabetes: SGLT-2 inhibitors to be offered as first line treatment in major guidance "shake-up". BMJ 2025;390:r1777.
PMID: 40835393